The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Authors
Keywords
-
Journal
Nutrients
Volume 12, Issue 6, Pages 1860
Publisher
MDPI AG
Online
2020-06-23
DOI
10.3390/nu12061860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of motor complications in early Parkinson's disease: A prospective cohort study
- (2019) Mark J. Kelly et al. MOVEMENT DISORDERS
- Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A ) and cytochrome P450 1A2 (CYP1A2 ) on Parkinson's disease risk
- (2018) Iris Y. Kim et al. MOVEMENT DISORDERS
- Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
- (2018) Motoki Fujimaki et al. NEUROLOGY
- The association between early treatment with amantadine and delayed onset of levodopa-induced dyskinesia in patients with Parkinson’s disease
- (2018) T.L. Wu et al. PARKINSONISM & RELATED DISORDERS
- Gender Differences in Tea, Coffee, and Cognitive Decline in the Elderly: The Cardiovascular Health Study
- (2018) Lenore Arab et al. JOURNAL OF ALZHEIMERS DISEASE
- Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
- (2018) Run Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Caffeine, creatine, GRIN2A and Parkinson's disease progression
- (2017) David K. Simon et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Health benefits of methylxanthines in neurodegenerative diseases
- (2017) Ainhoa Oñatibia-Astibia et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Onset and progression factors in Parkinson’s disease: A systematic review
- (2017) Rosemary Martino et al. NEUROTOXICOLOGY
- Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation
- (2017) Byron Carpenter et al. Frontiers in Pharmacology
- Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
- (2017) Gary W. Arendash et al. JOURNAL OF ALZHEIMERS DISEASE
- Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
- (2017) Marjo H. Eskelinen et al. JOURNAL OF ALZHEIMERS DISEASE
- Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat
- (2016) Siamak Reyhani-Rad et al. Acta Cirurgica Brasileira
- Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2
- (2016) Yu-Hsuan Chuang et al. NEUROEPIDEMIOLOGY
- Caffeine consumption and the 4-year progression of de novo Parkinson's disease
- (2016) Marcello Moccia et al. PARKINSONISM & RELATED DISORDERS
- Motor complications in an incident Parkinson's disease cohort
- (2015) N. W. Scott et al. EUROPEAN JOURNAL OF NEUROLOGY
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- How to optimize the treatment of early stage Parkinson’s disease
- (2015) Fabrizio Stocchi et al. Translational Neurodegeneration
- Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions
- (2014) João Ananias Machado-Filho et al. BEHAVIOURAL BRAIN RESEARCH
- A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
- (2013) Giulia Ambrosi et al. JOURNAL OF NEURAL TRANSMISSION
- Determinants of delayed diagnosis in Parkinson’s disease
- (2013) David P. Breen et al. JOURNAL OF NEUROLOGY
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease
- (2013) Krystyna Gołembiowska et al. NEUROTOXICITY RESEARCH
- Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
- (2012) R. Liu et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Parkinson's disease: Evidence for environmental risk factors
- (2012) Karl Kieburtz et al. MOVEMENT DISORDERS
- Caffeine and risk of Parkinson's disease in a large cohort of men and women
- (2012) Natalia Palacios et al. MOVEMENT DISORDERS
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- A Meta-Analysis of Tea Drinking and Risk of Parkinson's Disease
- (2012) Feng-Jiao Li et al. TheScientificWorldJOURNAL
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies
- (2010) Catherine J. Wei et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Genetics of caffeine consumption and responses to caffeine
- (2010) Amy Yang et al. PSYCHOPHARMACOLOGY
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smoking and tea consumption delay onset of Parkinson's disease
- (2008) Boris Kandinov et al. PARKINSONISM & RELATED DISORDERS
- The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat
- (2008) John E. Kelsey et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now